To avoid secondary malignancy BRAF inhibitor should be associated
to anti HSP90 (reduce stress associated side effects)
or the MTOR Inhibitors
or drugs that may affect the VHL/HIF-1 .
Is MEK inhibition a marker of RASK, it is the site of endothelial - epithelial interchange?
No comments:
Post a Comment